Citation 135114

NEAMATI,N: HONG,H: MAZUMDER,A: WANG,S: SUNDER,S: NICKLAUS,MC: MILNE,GWA: PROKSA,B: POMMIER,Y:. (1997). DEPSIDES AND DEPSIDONES AS INHIBITORS OF HIV-1 INTEGRASE: DISCOVERY OF NOVEL INHIBITORS THROUGH 3D DATABASE SEARCHING.. 40(6)

Citation Details

Title	DEPSIDES AND DEPSIDONES AS INHIBITORS OF HIV-1 INTEGRASE: DISCOVERY OF NOVEL INHIBITORS THROUGH 3D DATABASE SEARCHING.
Authors	NEAMATI,N: HONG,H: MAZUMDER,A: WANG,S: SUNDER,S: NICKLAUS,MC: MILNE,GWA: PROKSA,B: POMMIER,Y:
Year	1997
Volume	40
Issue	6

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIRENSIC ACID	ACTIVE
2	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIRENSIC ACID	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VIRENSIC ACID	WEAK ACTIVITY
4	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GRANULATINE	ACTIVE
5	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GRANULATINE	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GRANULATINE	WEAK ACTIVITY
7	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STICTIC ACID	ACTIVE
8	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STICTIC ACID	ACTIVE
9	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARELLIC ACID,CHLORO:	ACTIVE
10	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARELLIC ACID,CHLORO:	ACTIVE
11	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSODIC ACID	WEAK ACTIVITY
12	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSODIC ACID	WEAK ACTIVITY
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHYSODIC ACID	WEAK ACTIVITY
14	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LOBARIC ACID,NOR:	WEAK ACTIVITY
15	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LOBARIC ACID,NOR:	WEAK ACTIVITY
16	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALAZINIC ACID	WEAK ACTIVITY
17	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALAZINIC ACID	WEAK ACTIVITY
18	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARELLIC ACID	WEAK ACTIVITY
19	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARELLIC ACID	ACTIVE
20	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATRANORIN	WEAK ACTIVITY
21	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATRANORIN	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ATRANORIN	WEAK ACTIVITY
23	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	USNIC ACID	WEAK ACTIVITY
24	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	USNIC ACID	WEAK ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	USNIC ACID	WEAK ACTIVITY

Citation 135114

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1